Published in Cancer Res on December 01, 1979
Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion. Proc Natl Acad Sci U S A (1980) 1.94
Identification of receptors for phorbol ester tumor promoters in intact mammalian cells and of an inhibitor of receptor binding in biologic fluids. Proc Natl Acad Sci U S A (1981) 1.59
Studies on mechanism of action of anti-tumor-promoting agents: their specificity in two-stage promotion. Proc Natl Acad Sci U S A (1980) 1.47
Stimulation of human gamma interferon production by diterpene esters. Infect Immun (1981) 1.45
Overview of tumor promotion in animals. Environ Health Perspect (1983) 1.43
Indole alkaloids: dihydroteleocidin B, teleocidin, and lyngbyatoxin A as members of a new class of tumor promoters. Proc Natl Acad Sci U S A (1981) 1.35
Down regulation of specific binding of [20-3H]phorbol 12,13-dibutyrate and phorbol ester-induced differentiation of human promyelocytic leukemia cells. Proc Natl Acad Sci U S A (1981) 1.34
Specific binding of phorbol ester tumor promoters to intact primary epidermal cells from Sencar mice. Proc Natl Acad Sci U S A (1981) 1.26
Skin tumor promotion by phorbol esters is a two-stage process. Proc Natl Acad Sci U S A (1981) 1.10
Defective responses of transformed keratinocytes to terminal differentiation stimuli. Their role in epidermal tumour promotion by phorbol esters and by deep skin wounding. Br J Cancer (1985) 1.06
alpha-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin. Proc Natl Acad Sci U S A (1982) 0.96
Tumor promoters cause a rapid and reversible inhibition of the formation and maintenance of electrical cell coupling in culture. Proc Natl Acad Sci U S A (1981) 0.92
Induction of granulocyte-macrophage colony-stimulating activity in mouse skin by inflammatory agents and tumor promoters. EMBO J (1983) 0.85
Suppression of the first stage of phorbol 12-tetradecanoate 13-acetate-effected tumor promotion in mouse skin by nontoxic inhibition of DNA synthesis. Proc Natl Acad Sci U S A (1984) 0.76
New classes of environmental tumor promoters: indole alkaloids and polyacetates. Environ Health Perspect (1983) 0.75
In Vivo Availability of Pro-Resolving Lipid Mediators in Oxazolone Induced Dermal Inflammation in the Mouse. PLoS One (2015) 0.75
In Vitro models and methods for bioassay and studies of cellular mechanisms. Environ Health Perspect (1981) 0.75
Local anesthetics inhibit induction of ornithine decarboxylase by the tumor promoter 12-O-tetradecanoylphorbol 13-acetate. Proc Natl Acad Sci U S A (1980) 0.75
"Differentiation Induction" culture of human leukemic myeloid cells stimulates high production of macrophage differentiation inducing factor. Cytotechnology (1991) 0.75
The function and mechanism of promoters of carcinogenesis. CRC Crit Rev Toxicol (1974) 3.36
Induction of the polyamine-biosynthetic enzymes in mouse epidermis by tumor-promoting agents. Cancer Res (1975) 2.14
A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene (2001) 2.08
Wnt/beta-catenin signaling induces the expression and activity of betaTrCP ubiquitin ligase receptor. Mol Cell (2000) 2.02
Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion. Proc Natl Acad Sci U S A (1980) 1.94
Regulation of connexin 43-mediated gap junctional intercellular communication by Ca2+ in mouse epidermal cells is controlled by E-cadherin. J Cell Biol (1991) 1.94
Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating compound. Science (1981) 1.63
Comparison of the tumor-initiating activity of 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene in female SENCAR and CS-1 mice. Carcinogenesis (1980) 1.55
Phorbol esters stimulate DNA synthesis and ornithine decarboxylase activity in mouse epidermal cell cultures. Nature (1976) 1.54
Correlation of the inhibition by retinoids of tumor promoter-induced mouse epidermal ornithine decarboxylase activity and of skin tumor promotion. Cancer Res (1979) 1.52
Identification and primary structure of a calmodulin binding domain of the Ca2+ pump of human erythrocytes. J Biol Chem (1988) 1.50
Pulmonary function profile in patients with benign goiters without symptoms of respiratory compromise and the early effect of thyroidectomy. J Postgrad Med (2008) 1.48
Evidence that the centrally and peripherally located cells in the murine epidermal proliferative unit are two distinct cell populations. J Invest Dermatol (1985) 1.47
Studies on mechanism of action of anti-tumor-promoting agents: their specificity in two-stage promotion. Proc Natl Acad Sci U S A (1980) 1.47
Fas-mediated cell death promoted by opioids. Nature (1999) 1.45
15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells. J Natl Cancer Inst (2000) 1.43
Overview of tumor promotion in animals. Environ Health Perspect (1983) 1.43
Inhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886. Biochem J (2001) 1.42
Evidence that a slowly cycling subpopulation of adult murine epidermal cells retains carcinogen. Cancer Res (1986) 1.41
Protein kinase activity associated with a phorbol ester receptor purified from mouse brain. Cancer Res (1983) 1.37
Induction of the polyamine-biosynthetic enzymes in mouse epidermis and their specificity for tumor promotion. Cancer Res (1975) 1.36
Chronic restraint stress promotes lymphocyte apoptosis by modulating CD95 expression. J Exp Med (2000) 1.34
Identification of a calcium- and phospholipid- dependent phorbol ester binding activity in the soluble fraction of mouse tissues. Biochem Biophys Res Commun (1983) 1.34
Down regulation of specific binding of [20-3H]phorbol 12,13-dibutyrate and phorbol ester-induced differentiation of human promyelocytic leukemia cells. Proc Natl Acad Sci U S A (1981) 1.34
15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells. Cancer Res (2000) 1.31
Studies on the mechanism of skin tumor promotion. Cancer Res (1970) 1.29
Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis by vitamin A analogs (retinoids). Cancer Res (1978) 1.27
Protein kinase C-epsilon transgenic mice: a unique model for metastatic squamous cell carcinoma. Cancer Res (2001) 1.26
Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity. Oncogene (2006) 1.26
Comparison of two-stage epidermal carcinogenesis initiated by 7,12-dimethylbenz(a)anthracene or N-methyl-N'-nitro-N-nitrosoguanidine in newborn and adult SENCAR and BALB/c mice. Cancer Res (1981) 1.26
Specific binding of phorbol ester tumor promoters to intact primary epidermal cells from Sencar mice. Proc Natl Acad Sci U S A (1981) 1.26
The binding of beta-propiolactone to mouse skin DNA in vivo; its correlation with tumor-initiating activity. Cancer Res (1966) 1.25
Transcriptional regulation of cyclooxygenase-2 in mouse skin carcinoma cells. Regulatory role of CCAAT/enhancer-binding proteins in the differential expression of cyclooxygenase-2 in normal and neoplastic tissues. J Biol Chem (1998) 1.24
Expression pattern of a gene for a secreted metalloproteinase during late stages of tumor progression. Mol Carcinog (1988) 1.24
Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice. J Natl Cancer Inst (1999) 1.23
Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression. Cancer Res (2001) 1.22
Overexpression of cyclin D1 in mouse skin carcinogenesis. Oncogene (1993) 1.22
Vitamin A acid (retinoic acid), a potent inhibitor of 12-O-tetradecanoyl-phorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis. Cancer Res (1977) 1.22
The rate of activation by calmodulin of isoform 4 of the plasma membrane Ca(2+) pump is slow and is changed by alternative splicing. J Biol Chem (1999) 1.21
Marked differences in the skin tumor-initiating activities of the optical enantiomers of the diastereomeric benzo(a)pyrene 7,8-diol-9,10-epoxides. Cancer Res (1979) 1.20
The Ca2+ affinity of the plasma membrane Ca2+ pump is controlled by alternative splicing. J Biol Chem (1994) 1.20
Progressive dysplasia and aneuploidy are hallmarks of mouse skin papillomas: relevance to malignancy. Proc Natl Acad Sci U S A (1987) 1.19
Phorbol esters stimulate the rapid release of choline from prelabelled cells. Carcinogenesis (1981) 1.19
A highly active 120-kDa truncated mutant of the plasma membrane Ca2+ pump. J Biol Chem (1993) 1.18
The role of epidermal aryl hydrocarbon hydroxylase in the covalent binding of polycyclic hydrocarbon to DNA and its relationship to tumor initiation. Biochem Biophys Res Commun (1976) 1.18
Detection of isoform 4 of the plasma membrane calcium pump in human tissues by using isoform-specific monoclonal antibodies. Biochem J (1996) 1.17
Cryptococcal infection in patients with clinically diagnosed meningitis in a tertiary care center. Neurol India (2003) 1.15
Improved HPLC method for the simultaneous determination of allantoin, uric acid and creatinine in cattle urine. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 1.15
Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development. Oncogene (2006) 1.13
Transgenic mice overexpressing protein kinase C epsilon in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion. Cancer Res (2000) 1.13
Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose? Diabetologia (2010) 1.13
A pilot study of same day sputum smear examination, its feasibility and usefulness in diagnosis of pulmonary TB. Indian J Tuberc (2011) 1.12
The hamster cheek pouch carcinogenesis model. J Cell Biochem Suppl (1993) 1.12
Tumor-promoting activity of phorbol and four diesters of phorbol in mouse skin. Cancer Res (1971) 1.12
Transgenic mice overexpressing protein kinase Cdelta in the epidermis are resistant to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res (1999) 1.11
Epidermal cell proliferation and promoting ability of phorbol esters. J Natl Cancer Inst (1976) 1.11
Promotion of carcinomas by repeated abrasion in initiated skin of mice. Cancer Res (1981) 1.10
Murine susceptibility to two-stage skin carcinogenesis is influenced by the agent used for promotion. Carcinogenesis (1984) 1.10
The stimulation of phospholipid metabolism in mouse skin following phorbol ester treatment. Biochim Biophys Acta (1972) 1.09
Malignant progression of papilloma-derived keratinocytes: differential effects of the ras, neu, and p53 oncogenes. Mol Carcinog (1988) 1.08
Comparative tumor-initiating activity of complex mixtures from environmental particulate emissions on SENCAR mouse skin. J Natl Cancer Inst (1982) 1.08
Induction of dark keratinocytes by 12-O-tetradecanoylphorbol-13-acetate and mezerein as an indicator of tumor-promoting efficiency. Carcinogenesis (1980) 1.08
Dose-response studies on the ability of 7,12-dimethylbenz(alpha)anthracene and benz(alpha)anthracene to initiate skin tumors. J Natl Cancer Inst (1974) 1.08
Differential effects of retinoic acid and 7,8-benzoflavone on the induction of mouse skin tumors by the complete carcinogenesis process and by the initiation-promotion regimen. Cancer Res (1982) 1.08
Avicins, a family of triterpenoid saponins from Acacia victoriae (Bentham), suppress H-ras mutations and aneuploidy in a murine skin carcinogenesis model. Proc Natl Acad Sci U S A (2001) 1.08
THE VITAMIN CONTENT OF CASEIN. Science (1945) 1.07
Increased expression of p50-NF-kappaB and constitutive activation of NF-kappaB transcription factors during mouse skin carcinogenesis. Oncogene (1999) 1.07
Protein kinase C activates the plasma membrane Ca2+ pump isoform 4b by phosphorylation of an inhibitory region downstream of the calmodulin-binding domain. J Biol Chem (1996) 1.07
Relation of the induction of epidermal ornithine decarboxylase and hyperplasia to the different skin tumor-promotion susceptibilities of protein kinase C alpha, -delta and -epsilon transgenic mice. Int J Cancer (2001) 1.07
Studies on the mechanisms involved in multistage carcinogenesis in mouse skin. J Cell Biochem (1982) 1.07
Sequential trisomization of chromosomes 6 and 7 in mouse skin premalignant lesions. Mol Carcinog (1989) 1.06
Aneuploidy, an early event in mouse skin tumor development. Carcinogenesis (1986) 1.06
Plasma membrane calcium pump and 28-kDa calcium binding protein in cells of rat kidney distal tubules. Am J Physiol (1989) 1.06
Inhibition of tumor initiation and promotion by anti-inflammatory agents. J Natl Cancer Inst (1973) 1.06
Induction of beta-transducin repeat-containing protein by JNK signaling and its role in the activation of NF-kappaB. J Biol Chem (2001) 1.05
Intraoperative frozen section for the evaluation of extrathyroidal extension in papillary thyroid cancer. World J Surg (2015) 1.05
Uptake of insulin by plasmalemma and Golgi subcellular fractions of rat liver. J Biol Chem (1980) 1.05
Protein kinase C regulates Fas (CD95/APO-1) expression. J Immunol (1998) 1.05
Phosphorylation of histones is stimulated by phorbol esters in quiescent Reuber H35 hepatoma cells. J Biol Chem (1986) 1.05
Effects of antiinflammatory agents on mouse skin tumor promotion, epidermal DNA synthesis, phorbol ester-induced cellular proliferation, and production of plasminogen activator. Cancer Res (1977) 1.04
Effect of phorbol ester tumor promoters on the expression of melanogenesis in B-16 melanoma cells. Cancer Res (1979) 1.04
Separation of epidermal cells by density centrifugation: a new technique for studies on normal and pathological differentiation. J Cutan Pathol (1982) 1.03